SOPHiA GENETICS SA (SOPH)
Who owns SOPHiA GENETICS SA (SOPH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 65.3% of the shares are freely tradable; institutional investors hold 48.0%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Generation Investment Management LLP | 8.09 | 6,789,560 | +0.0 | 03/31/2026 |
| Akre Capital Management, LLC | 4.43 | 3,719,140 | +0.0 | 03/31/2026 |
| Banque Pictet & Cie SA | 2.63 | 2,208,280 | +0.0 | 06/30/2026 |
| Soleus Capital Management, L.P. | 2.21 | 1,850,000 | +0.0 | 03/31/2026 |
| Royce & Associates, LP | 2.17 | 1,816,312 | +322.1 | 03/31/2026 |
| Principal Financial Group Inc | 1.68 | 1,409,242 | +0.7 | 03/31/2026 |
| Alta Wealth Advisors LLC | 1.68 | 1,409,160 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Columbia Small Cap Growth | 1.48 | 1,244,236 | +0.0 | 06/30/2026 |
| Principal SmallCap R5 | 1.29 | 1,078,936 | +75.4 | 06/30/2026 |
| Principal U.S. Small Cap Equity | 1.29 | 1,078,936 | +66.2 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 27. Jul 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | 5.66 | 28,306 |
| 20. Apr 2026 | Jurgi Camblong | CEO | Sell | 4,486 | 5.21 | 23,372 |
| 20. Apr 2026 | Kevin Puylaert | Insider | Sell | 33 | 5.08 | 168 |
| 20. Apr 2026 | Manuela Valente | Insider | Sell | 380 | 5.20 | 1,976 |
| 20. Apr 2026 | Philippe Menu | Insider | Sell | 608 | 5.20 | 3,162 |
| 20. Apr 2026 | Ross Muken | President | Sell | 760 | 5.20 | 3,952 |
| 20. Apr 2026 | Well Daan Van | Insider | Sell | 684 | 5.20 | 3,557 |
| 20. Apr 2026 | Zhenyu Xu | Insider | Sell | 608 | 5.21 | 3,168 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.